EOS-448

iTeos Belgium SA · Phase 1 active Small molecule

At a glance

Generic name	EOS-448
Also known as	EOS884448, GSK4428859, belrestotug
Sponsor	iTeos Belgium SA
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

EOS-448 CI brief — competitive landscape report
EOS-448 updates RSS · CI watch RSS
iTeos Belgium SA portfolio CI